New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tourmaline Bio, Inc.
TRML
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

376M

Biotechnology

Next Earning date - 18 Mar 2025

376M

Biotechnology

Next Earning date - 18 Mar 2025

13.83USD

Shape0.74 ( 5.65%)
moonAfter-hours 15.89$arrow-right-up2.06 (14.93%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-9%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

71%

Quote Panel

Shape
Updated March 10, 2025
1W 17.95 % 1M 13.74 % 3M -39.91 % 1Y -64.92 %

Key Metrics

Shape
  • Market Cap

    375.66M


  • Shares Outstanding

    25.64M


  • Share in Float

    16.01M


  • Dividende

    0


  • Earning Date

    18 Mar 2025


  • Price Target

    14.65


  • Average Volume

    264727


  • Beta

    2.3705313


  • Range

    11.87-48.31


  • Industry

    Biotechnology


  • Website

    https://www.tourmalinebio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TRML

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

ShapeNaN%

2025-Revenue

$3.50

Shape-349%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

42.00(186.69%)

Number of analyst

1

Last analyst upgrade/downgrade

Wedbush

initialise

Previous: Not converted

2025-03-06

Now: Outperform

BMO Capital

initialise

Previous: Not converted

2024-12-05

Now: Outperform

Cantor Fitzgerald

initialise

Previous: Not converted

2024-10-15

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.00
vs -3.48

Q1.23

arrow
arrow

N/A

-0.37
vs -4.40

Q2.23

arrow
arrow

N/A

-0.20
vs -0.00

Q3.23

arrow
arrow

N/A

-1.64
vs -0.00

Q4.23

arrow
arrow

N/A

-0.81
vs -0.00

Q1.24

arrow
arrow

N/A

-0.55
vs -0.37

Q2.24

arrow
arrow

N/A

-0.68
vs -0.20

Q3.24

arrow
arrow

N/A

-0.78
vs -1.64

Q4.24

arrow
arrow

N/A

-0.86
vs -0.81

Q1.25

arrow
arrow

N/A

-0.87
vs -0.55

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

2.3M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+0%

0
vs -0.00

Q1.23

arrow
arrow

-5%

-0.05
vs 0

Q2.23

arrow
arrow

+38%

0.38
vs -0.05

Q3.23

arrow
arrow

-5%

-0.05
vs 0.38

Q4.23

arrow
arrow

+1%

0.01
vs -0.05

Q1.24

arrow
arrow

-4%

-0.04
vs 0.01

Q2.24

arrow
arrow

-5%

-0.05
vs -0.04

Q3.24

arrow
arrow

-6%

-0.06
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.23

arrow
arrow

54

54
vs NA

NA

Q1.24

arrow
arrow

105

105
vs 54

94%

Q2.24

arrow
arrow

86

86
vs 105

-18%

Q3.24

arrow
arrow

92

92
vs 86

7%

Q4.24

arrow
arrow

102

102
vs 92

11%

Earnings Growth

Latest News